• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多粘菌素B体外联合治疗对延缓肺炎克雷伯菌耐药性的影响及多粘菌素诱导耐药机制的研究

Effects of in vitro combination therapy with polymyxin B on delaying resistance in Klebsiella pneumoniae and insights into the mechanisms of polymyxin-induced resistance.

作者信息

Zhang Huanhuan, Feng Wei, Sun Fengjun, Xu Te, Qian Yan

机构信息

Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China; Department of Pharmacy, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Department of Pharmacy, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

出版信息

J Glob Antimicrob Resist. 2025 Jun;43:143-154. doi: 10.1016/j.jgar.2025.04.009. Epub 2025 Apr 29.

DOI:10.1016/j.jgar.2025.04.009
PMID:40311761
Abstract

OBJECTIVE

This study aimed to investigate the effects of polymyxin B (PMB) in combination with other antibiotics on delaying resistance in Klebsiella pneumoniae and to explore the mechanisms underlying PMB-induced resistance.

METHODS

In vitro continuous induction experiments were performed to observe changes in drug susceptibility with PMB alone vs. in combination. RNA-seq, quantitative reverse transcription PCR, and proteomic analyses were utilized to evaluate differential gene and protein expression between induced-resistant strains and those exhibiting delayed resistance. Then, gene knockout experiments were performed to validate the functional roles of relevant genes.

RESULTS

These findings indicated that PMB alone could induce resistance within 1-2 d, whereas the combination with amikacin (AMK) or tigecycline delayed the onset of resistance by 6 d. RNA-seq, quantitative reverse transcription PCR, and proteomic analyses revealed significant upregulation of nlpE, two-component systems, and AcrAB-TolC efflux pump-associated genes in PMB-induced resistant strains, whereas these genes were downregulated in the delayed resistant strains of PMB combined with AMK. Deletion and complementation experiments demonstrated that the expression levels of two-component systems and efflux pump-related genes were downregulated in nlpE knockout strains. Furthermore, PMB induction experiments revealed a significant upregulation of PmrA, PhoP, PhoQ, PagP, and AcrB proteins associated with cationic antimicrobial peptide pathways in the wild-type and nlpE complemented strains, whereas no differential change was observed in the nlpE knockout strain.

CONCLUSIONS

nlpE contributes to PMB resistance by modulating the AcrAB-TolC efflux pump and the PhoP/Q and PmrA/B two-component systems. The combined use of PMB with AMK effectively delays the development of resistance in K. pneumoniae through the regulation of nlpE and its associated signalling pathways.

摘要

目的

本研究旨在探讨多粘菌素B(PMB)与其他抗生素联合使用对延缓肺炎克雷伯菌耐药性的影响,并探索PMB诱导耐药的机制。

方法

进行体外连续诱导实验,观察单独使用PMB与联合使用时药物敏感性的变化。利用RNA测序、定量逆转录PCR和蛋白质组学分析评估诱导耐药菌株与表现出延缓耐药性的菌株之间基因和蛋白质表达的差异。然后,进行基因敲除实验以验证相关基因的功能作用。

结果

这些发现表明,单独使用PMB可在1 - 2天内诱导耐药,而与阿米卡星(AMK)或替加环素联合使用可将耐药发生时间推迟6天。RNA测序、定量逆转录PCR和蛋白质组学分析显示,在PMB诱导的耐药菌株中,nlpE、双组分系统和AcrAB - TolC外排泵相关基因显著上调,而在PMB与AMK联合的延缓耐药菌株中这些基因下调。缺失和互补实验表明,在nlpE敲除菌株中双组分系统和外排泵相关基因的表达水平下调。此外,PMB诱导实验显示,在野生型和nlpE互补菌株中,与阳离子抗菌肽途径相关的PmrA、PhoP、PhoQ、PagP和AcrB蛋白显著上调,而在nlpE敲除菌株中未观察到差异变化。

结论

nlpE通过调节AcrAB - TolC外排泵以及PhoP/Q和PmrA/B双组分系统来促进对PMB的耐药性。PMB与AMK联合使用通过调节nlpE及其相关信号通路有效延缓肺炎克雷伯菌耐药性的发展。

相似文献

1
Effects of in vitro combination therapy with polymyxin B on delaying resistance in Klebsiella pneumoniae and insights into the mechanisms of polymyxin-induced resistance.多粘菌素B体外联合治疗对延缓肺炎克雷伯菌耐药性的影响及多粘菌素诱导耐药机制的研究
J Glob Antimicrob Resist. 2025 Jun;43:143-154. doi: 10.1016/j.jgar.2025.04.009. Epub 2025 Apr 29.
2
Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.多黏菌素 B 和替加环素联合克服耐碳青霉烯类肺炎克雷伯菌异质性耐药的效果。
Microbiol Spectr. 2021 Oct 31;9(2):e0015221. doi: 10.1128/Spectrum.00152-21. Epub 2021 Oct 27.
3
Polymyxin B combined with amikacin delays the resistance of Klebsiella pneumoniae to polymyxin B by modulating the expression of NlpE.多粘菌素B联合阿米卡星通过调节NlpE的表达延缓肺炎克雷伯菌对多粘菌素B的耐药性。
Infect Genet Evol. 2025 Sep;133:105780. doi: 10.1016/j.meegid.2025.105780. Epub 2025 Jun 4.
4
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.用于产碳青霉烯酶肺炎克雷伯菌的三联抗生素联合疗法:一项系统评价
Ann Clin Microbiol Antimicrob. 2017 Nov 25;16(1):76. doi: 10.1186/s12941-017-0249-2.
5
Biofilm and surface-motility profiles under polymyxin B stress in multidrug-resistant KAPE pathogens isolated from Ghanaian hospital ICUs.从加纳医院重症监护病房分离出的多重耐药性KAPE病原体在多粘菌素B胁迫下的生物膜和表面运动特征。
Exp Biol Med (Maywood). 2025 Jun 6;250:10350. doi: 10.3389/ebm.2025.10350. eCollection 2025.
6
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.治疗产碳青霉烯酶肺炎克雷伯菌(KPC)感染:已发表的病例系列和病例报告综述。
Ann Clin Microbiol Antimicrob. 2012 Dec 13;11:32. doi: 10.1186/1476-0711-11-32.
7
Antibacterial efficacy of cefoperazone/sulbactam in combination with various antimicrobials against carbapenem-resistant Klebsiella pneumoniae.头孢哌酮/舒巴坦联合多种抗菌药物对耐碳青霉烯类肺炎克雷伯菌的抗菌疗效
Acta Microbiol Immunol Hung. 2025 Apr 23;72(2):106-112. doi: 10.1556/030.2025.02577. Print 2025 Jun 20.
8
Drug resistance phenotypes of clinical Klebsiella pneumoniae isolates in the past 20 years in China: A systematic review and meta-analysis.中国过去20年临床肺炎克雷伯菌分离株的耐药表型:一项系统评价和荟萃分析。
Int J Antimicrob Agents. 2025 Aug;66(2):107520. doi: 10.1016/j.ijantimicag.2025.107520. Epub 2025 Apr 20.
9
Activity of polymyxin B combined with cefepime-avibactam against the biofilms of polymyxin B-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae in in vitro and in vivo models.多黏菌素 B 联合头孢吡肟-阿维巴坦对体外和体内模型中多黏菌素 B 耐药铜绿假单胞菌和肺炎克雷伯菌生物膜的活性。
BMC Microbiol. 2024 Oct 16;24(1):409. doi: 10.1186/s12866-024-03571-3.
10
Molecular and epidemiological characterization of carbapenem-resistant hypervirulent in Huaian, China (2022-2024): a retrospective study.中国淮安耐碳青霉烯类高毒力菌株的分子与流行病学特征(2022 - 2024年):一项回顾性研究
Front Cell Infect Microbiol. 2025 Jun 4;15:1569004. doi: 10.3389/fcimb.2025.1569004. eCollection 2025.

引用本文的文献

1
Molecular characteristics and antimicrobial susceptibility of carbapenem-resistant in a multicenter study in Ningbo, China.中国宁波一项多中心研究中耐碳青霉烯类细菌的分子特征及抗菌药敏情况
Front Microbiol. 2025 Jul 21;16:1628592. doi: 10.3389/fmicb.2025.1628592. eCollection 2025.